Literature DB >> 8077269

Avascular necrosis of bone after cardiac transplantation. Prevalence and relationship to administration and dosage of steroids.

G Bradbury1, J Benjamin, J Thompson, E Klees, J Copeland.   

Abstract

We studied the relationship of the administration and dosage of steroids to the development of avascular necrosis of bone in 168 patients who had had a heart transplantation (156 patients) or a heart and lung transplantation (twelve patients). One hundred and forty-one of the patients were male and twenty-seven were female. The average age was forty-five years (range, seven to sixty-six years). The average duration of follow-up was forty months (range, twelve to eighty months). Avascular necrosis developed in five patients (3 per cent). The femoral head was involved in three patients (bilaterally in two and unilaterally in one), the medial femoral condyle was involved bilaterally in one, and several sites were involved in the fifth patient. The avascular necrosis was diagnosed an average of five months (range, two to eleven months) after the transplantation. In order to evaluate the influence of the dosage of the steroids on the development of avascular necrosis of bone, the doses of prednisone and Solu-Medrol (methylprednisolone) at one week, one month, six months, and one year after the transplantation were calculated for each patient. There was no association between the cumulative dose of prednisone and the development of avascular necrosis. There was, however, a strong statistical association (p = 0.005), as determined with pooled two-tailed variance analysis, between the cumulative dose of Solu-Medrol administered in the first month after the transplantation and the development of avascular necrosis.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 8077269     DOI: 10.2106/00004623-199409000-00014

Source DB:  PubMed          Journal:  J Bone Joint Surg Am        ISSN: 0021-9355            Impact factor:   5.284


  8 in total

1.  Prevalence and Associations of Avascular Necrosis of the Hip in a Large Well-characterized Cohort of Patients With Inflammatory Bowel Disease.

Authors:  Vineet S Rolston; Anish V Patel; Thomas J Learch; Dalin Li; Dmitry Karayev; Chadwick Williams; Madhavi L Siddanthi; Stephan R Targan; Michael H Weisman; Dermot P B McGovern
Journal:  J Clin Rheumatol       Date:  2019-01       Impact factor: 3.517

Review 2.  Steroid induced osteonecrosis: An analysis of steroid dosing risk.

Authors:  Christian Powell; Christopher Chang; Stanley M Naguwa; Gurtej Cheema; M Eric Gershwin
Journal:  Autoimmun Rev       Date:  2010-07-09       Impact factor: 9.754

Review 3.  Osteonecrosis is not a predictor of poor outcomes in primary total hip arthroplasty: a systematic literature review.

Authors:  Henning R Johannson; Michael G Zywiel; David R Marker; Lynne C Jones; Mike S McGrath; Michael A Mont
Journal:  Int Orthop       Date:  2010-02-25       Impact factor: 3.075

4.  Steroid effects on osteogenesis through mesenchymal cell gene expression.

Authors:  Xudong Li; Li Jin; Quanjun Cui; Gwo-Jaw Wang; Gary Balian
Journal:  Osteoporos Int       Date:  2004-06-15       Impact factor: 4.507

5.  Increased risk of revision in patients with non-traumatic femoral head necrosis.

Authors:  Camilla Bergh; Ann M Fenstad; Ove Furnes; Göran Garellick; Leif I Havelin; Søren Overgaard; Alma B Pedersen; Keijo T Mäkelä; Pekka Pulkkinen; Maziar Mohaddes; Johan Kärrholm
Journal:  Acta Orthop       Date:  2013-12-20       Impact factor: 3.717

6.  Association between genetic polymorphisms and osteonecrosis in steroid treatment populations: a detailed stratified and dose-response meta-analysis.

Authors:  Jun Yang; Ming Jing; Xiaoge Yang
Journal:  Biosci Rep       Date:  2019-05-14       Impact factor: 3.840

Review 7.  High-Dose Corticosteroid Use and Risk of Hip Osteonecrosis: Meta-Analysis and Systematic Literature Review.

Authors:  Michael A Mont; Robert Pivec; Samik Banerjee; Kimona Issa; Randa K Elmallah; Lynne C Jones
Journal:  J Arthroplasty       Date:  2015-04-08       Impact factor: 4.757

8.  Joint Arthroplasties other than the Hip in Solid Organ Transplant Recipients.

Authors:  Arkan S Sayed-Noor
Journal:  Open Orthop J       Date:  2009-05-15
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.